Primer on Medical Genomics Part XIII: Ethical and Regulatory Issues

Hook, C. Christopher; DiMagno, Eugene P.; Tefferi, Ayalew
May 2004
Mayo Clinic Proceedings;May2004, Vol. 79 Issue 5, p645
Academic Journal
Ethics in the new genomics era has become an increasingly complex subject that often arouses passion and confusion. Although 50 years have elapsed since the elucidation of the DNA molecule, the recent near-complete sequencing of the human genome has sharply accelerated the incorporation of genetics into the medical mainstream. Along with these scientific advances, however, have surfaced challenges, liabilities, and issues regarding the processing and management of genetic information as they relate to core ethical principles such as respect for autonomy, beneficence, nonmaleficence, and justice. Institutions and state and federal governments have initiated systematic and preemptive measures in education, resource development, and protective legislation to address these cardinal ethical issues. Genetic research is also being scrutinized carefully by institutional review boards, an activity that should not be perceived as being adversarial but rather as a protective shield for investigators and research participants alike. Ultimately, it is hoped that genomics medicine will diminish rather than enhance existing sex-, race-, and socioeconomic class-based inequities in health care access and delivery. This article describes some but not all aspects of the ethical, legal, and social implications of genomics in clinical practice.


Related Articles

  • Genetic and Genomic Healthcare: Ethical Issues of Importance to Nurses. Lea, Dale Halsey // Online Journal of Issues in Nursing;2008, Vol. 13 Issue 1, p6 

    The complete sequencing of the human genome in 2003 has opened doors for new approaches to health promotion, maintenance, and treatment. Genetic research is now leading to a better understanding of the genetic components of common diseases, such as cancer, diabetes, and stroke, and creating new,...

  • Genomics and the Public Health Code of Ethics. Thomas, James C.; Irwin, Debra E.; Zuiker, Erin Shaugnessy; Millikan, Robert C. // American Journal of Public Health;Dec2005, Vol. 95 Issue 12, p2139 

    We consider the public health applications of genomic technologies as viewed through the lens of the public health code of ethics. We note, for example, the potential for genomics to increase our appreciation for the public health value of interdependence, the potential for some genomic tools to...

  • The Principles of the Belmont Report Revisited. Cassell, Eric J. // Hastings Center Report;Jul/Aug2000, Vol. 30 Issue 4, p12 

    Focuses on the principles applied in clinical medicine in Belmont, Tennessee. Discussion of the principle of beneficence; Recognition of the importance of the freedom of choice; Focus of medicine on functional abnormalities and pathophysiology of the disease; Development of medical ethics;...

  • Ethical Diversity and the Role of Conscience in Clinical Medicine. Genuis, Stephen J.; Lipp, Chris // International Journal of Family Medicine;2013, p1 

    In a climate of plurality about the concept of what is "good," one of the most daunting challenges facing contemporary medicine is the provision of medical care within the mosaic of ethical diversity. Juxtaposed with escalating scientific knowledge and clinical prowess has been the concomitant...

  • Integrating Genomics into Clinical Practice. Armstrong, Linlea // UBC Medical Journal;Feb2013, Vol. 4 Issue 2, p8 

    The article looks at the integration of genomics into the clinical practice. Particular focus is given to the use of genomic analyses in making diagnoses of many conditions that were suspected to be genetic. The application of genomics to obtain probabilistic assessments of clinical problems is...

  • The Power of Prediction: How Personal Genomics became a Policy Challenge. Prainsack, Barbara // OZP-Oesterreichische Zeitschrift für Politikwissenschaft;2011, Vol. 40 Issue 4, p401 

    This paper discusses how online genome-wide DNA tests that are marketed direct-to-consumer (DTC) have become policy challenges in many European and North American countries - despite the small number of people who have taken such tests world-wide. It is argued that interpretive approaches are...


    The majority of pancreatic diseases are associated with genetic polymorphisms. Recent breakthroughs in understanding the origin and pathways toward pancreatic diseases, and especially acute and chronic pancreatitis, reveal that specific variation in the genomic DNA sequence of individuals...

  • THE USE OF DNA PROBES IN DENTAL DIAGNOSIS AND THERAPY. QUIVEY, JR., R. G. // Advances in Dental Research;Dec1987, Vol. 1 Issue 1, p99 

    Recombinant DNA technology now allows for the development of genetic probes specific for a growing number of etiologic disease agents, including those suspected pathogens in the oral environment. The increasing refinement of DNA probe methodologies and sensitivities will ultimately permit their...

  • Tackling the Challenges of Clinical Trials in Palliative Care. Currow, David C.; Agar, Meera R.; Abernethy, Amy P. // Pharmaceutical Medicine - New Zealand;2011, Vol. 25 Issue 1, p7 

    There is an ethical imperative to provide the best quality of care for all people, including people at the end of life. In order to provide such care, each intervention used in clinical practice must be tested objectively for net clinical benefit (response and toxicity). For pharmacological and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics